The use of lepirudin in haemodialysis complicated with heparin-induced thrombocytopenia type II (HIT II)--dosage monitoring.
Kassimatis
Theodoros Ioannis
TI
Apostolou
Theofanis
T
Theodoridis
Theodoros
T
El Ali
Mahmut
M
Hadjiconstantinou
Valsamakis
V
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000139:chemically induced*
D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin; C083544:lepirudin